Robert E. Gagnon - Jan 8, 2024 Form 4 Insider Report for Bone Biologics Corp (BBLG)

Role
Director
Signature
/s/ Robert E. Gagnon
Stock symbol
BBLG
Transactions as of
Jan 8, 2024
Transactions value $
$0
Form type
4
Date filed
1/10/2024, 05:17 PM
Previous filing
Dec 20, 2023
Next filing
Jan 17, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BBLG Non-Employee Stock Option Award $0 +9 $0.00 9 Jan 8, 2024 Common Stock 9 $4.68 Direct F1
transaction BBLG Non-Employee Stock Option Award $0 +8.01 +0.1% $0.00 8.02K Jan 8, 2024 Common Stock 8.01K $4.68 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests and becomes exercisable on the date of the next annual meeting of the stockholders of the Company following the grant date.
F2 This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, 2,003 options are immediately exercisable with the remaining 6,003 options vesting and becoming exercisable in three equal installments on 3/12/2024, 6/12/2024, and 9/12/2024.